Drug recall · February 7, 2018
ZHANSHENG WEIGE CHAOYUE XILISHI tablets recall
Why: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
ZHANSHENG WEIGE CHAOYUE XILISHI tablets, 2000 mg, 6-count bottle, labeling is in foreign language
- Lots / codes
All Lots
- Quantity
- unknown
- Company
- A&H Focal Inc., Staten Island, NY
- Distribution
- NY and NJ through six retail stores named "Asian Food Markets"
- Initiated
- March 7, 2017 · Voluntary: Firm initiated
- Classified
- February 28, 2018
- Reported
- February 7, 2018
- Ended
- June 14, 2019
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.